Oncology
Cytotoxic and targeted therapies for solid and hematologic tumors, including injectable oncology programs.
Therapeutic Areas
Our portfolios are structured across the therapeutic areas where clinical demand, regulatory pathways and commercial opportunity converge.
Cytotoxic and targeted therapies for solid and hematologic tumors, including injectable oncology programs.
Injectables and specialty formulations used in intensive care, emergency and hospital settings.
Inhalation, nebulized and systemic therapies across asthma, COPD and respiratory infection.
Chronic-care cardiovascular portfolios spanning anti-hypertensives, lipid regulators and anticoagulants.
Neurology and psychiatry therapies including anti-epileptics, anti-depressants and neuroprotective agents.
Hormonal, gynecological and fertility-related formulations for both primary and specialty care.
Acid regulators, motility agents and hepatology-focused therapies for chronic GI conditions.
Broad and targeted anti-bacterial, anti-viral and anti-fungal portfolios for regulated and emerging markets.
Vitamins, minerals, probiotics and specialty nutritional formulations spanning preventive and adjunct-care segments.
Topical and systemic therapies across medical dermatology, cosmeceuticals and specialty skin conditions.
Looking for a specific molecule?
Share the therapy area and destination market — we'll return the country-specific product list on request.